Skip to main content
. Author manuscript; available in PMC: 2008 Nov 5.
Published in final edited form as: J Pain. 2008 Jul 16;9(11):991–998. doi: 10.1016/j.jpain.2008.05.006

Figure 2.

Figure 2

A: Footshock-induced bladder hypersensitivity is significantly attenuated by i.t. administration of a CRF2 receptor antagonist, aSVG30. Following 7 day exposure to the Footshock Treatment, VMRs of rats treated with i.t. aSVG30 were significantly less than VMRs of rats that were given i.t. vehicle. B: This effect was not observed after i.t. administration of antalarmin, a CRF1 receptor antagonist. * indicates p<0.05; ** indicates p<0.01. N=6-8/group.